Shreya Agrawal / rahejahospital.com
Jan 4, 2026, 14:51
Shreya Agrawal: Top 5 Practical Hematology Lessons from 2025 – Mild Cytopenias are Rarely “Incidental” and More
Dr Shreya Agrawal, Consultant Hematologist and Bone marrow transplant physician at S. L. Raheja Hospital – A Fortis Associate, shared a post on LinkedIn:
“Top 5 Practical Hematology Lessons from 2025
As 2025 comes to a close, everyday clinical practice reinforced a few important truths in hematology:
- Mild cytopenias are rarely “incidental”
Persistent anemia, thrombocytopenia, or leukopenia—especially in older adults—often represents early marrow pathology rather than age-related change. - Trends matter more than single reports
A stable pattern over time provides far more diagnostic value than one CBC within reference range. - Molecular tests are tools, not shortcuts
NGS and advanced panels are most useful when guided by clinical suspicion and careful patient selection. - Treatment decisions are increasingly biology-driven
Risk stratification, disease trajectory, and patient fitness now guide therapy more than absolute counts alone. - Supportive care shapes outcomes
Transfusion strategy, infection prevention, and thrombosis management directly influence survival and quality of life.
2025 was a reminder that good hematology is built on observation, follow-up, and thoughtful intervention. Looking ahead to applying these lessons with greater precision in 2026.”
Explore more posts for deeper insights into hemostasis with Hemostasis Today.
-
Feb 23, 2026, 13:02Deepak Yadav: What 2025 Evidence Tells Us About Stroke Care
-
Feb 23, 2026, 12:55Radoslaw Kaczmarek: Will AAV Gene Therapy for Hemophilia Trigger Tumorigenesis?
-
Feb 23, 2026, 12:46Heghine Khachatryan: More Granular Risk Stratification Framework for PE from The New 2026 AHA/ACC Guideline
-
Feb 23, 2026, 12:37Reza Shojaei: EU’s Critical Medicines Act and Plasma Resilience
-
Feb 23, 2026, 12:32Anirban Sen Gupta: Emily Mihalko Highlights PlateChek at MTEC
-
Feb 23, 2026, 12:25Ryan Williams: Excellent Highlights on The Heterogeneity of PRP Preparation
-
Feb 23, 2026, 12:10Peter Libby: hsCRP May Select Patients Who Can Benefit From Statins or Anti-inflammatory Therapy
-
Feb 23, 2026, 12:02Marios Georgakis: An Unprecedented for An Antithrombotic Therapy from OCEANIC-STROKE Trial
-
Feb 23, 2026, 11:37Charles Okyere Boadu: Blood Donation Helps Lower Your Risk of Stroke and Organ Damage